Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.08.29
中国中投证券有限责任公司关于公司变换部分逾额召募资金存放专项账户的核查意见
2013.08.29
2013年1-6月财务报告
2013.08.29
第二届董事会第二十六次聚会决议通告
2013.08.24
关于股东迁址及更名等的提醒性通告
2013.08.13
关于媒体报道的澄清通告
2013.08.02
关于设立全资子公司希望的通告
2013.07.31
2013年半年度业绩快报
2013.07.26
关于股票期权激励妄想已授予股票期权注销完成的通告
2013.07.13
关于公司作废股票期权激励妄想的会计处置惩罚意见
2013.07.13
第二届董事会第二十五次聚会决议通告
第一页
上一页
118
119
120
121
122
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】